SUMMARY
IMITREX (sumatriptan succinate) Injection is a selective 5-hydroxytryptamine1 receptor subtype agonist.
IMITREX Injection is indicated for 1) the acute treatment of migraine attacks with or without aura and 2) the acute treatment of cluster headache episodes.
IMITREX Injection is not for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS).
|